comparemela.com
Home
Live Updates
Novaliq Announces POSITIVE Topline Results for SECOND PHASE
Novaliq Announces POSITIVE Topline Results for SECOND PHASE
Novaliq Announces POSITIVE Topline Results for SECOND PHASE 3 TRIAL (ESSENCE-2) of CyclASol® in Dry Eye Disease
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Related Keywords
Germany ,
United States ,
Heidelberg ,
Baden Wüberg ,
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Christian Roesky ,
Novaliq Gmb ,
Prnewswire Novaliq ,
Johnd Sheppard ,
Simone Angstmann Mehr ,
Gmbh Co ,
Eastern Virginia Medical School ,
European Medicines Agency ,
Drug Administration ,
Health Sciences ,
Novaliq Inc ,
Eye Dryness Score ,
Mid Atlantic Medical Director ,
Eye Care ,
New Drug Application ,
Chief Executive Officer ,
Hopp Biotech ,
Media Contact ,
Technology ,
Business ,
Health ,
Europe ,
Pr Newswire ,
Clinical Trials ,